nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC1—manus—systemic scleroderma	0.0287	0.109	CbGeAlD
Vorinostat—HDAC1—manual digit—systemic scleroderma	0.0281	0.107	CbGeAlD
Vorinostat—HDAC2—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.0103	1	CbGdCrCtD
Vorinostat—NCOR1—connective tissue—systemic scleroderma	0.0103	0.039	CbGeAlD
Vorinostat—NCOR1—skin of body—systemic scleroderma	0.00928	0.0352	CbGeAlD
Vorinostat—HDAC3—connective tissue—systemic scleroderma	0.00901	0.0342	CbGeAlD
Vorinostat—HDAC8—digestive system—systemic scleroderma	0.00878	0.0333	CbGeAlD
Vorinostat—HDAC8—tendon—systemic scleroderma	0.00835	0.0317	CbGeAlD
Vorinostat—HDAC6—lung—systemic scleroderma	0.00826	0.0314	CbGeAlD
Vorinostat—HDAC1—connective tissue—systemic scleroderma	0.00825	0.0313	CbGeAlD
Vorinostat—HDAC3—skin of body—systemic scleroderma	0.00814	0.0309	CbGeAlD
Vorinostat—HDAC4—tendon—systemic scleroderma	0.00812	0.0308	CbGeAlD
Vorinostat—HDAC11—digestive system—systemic scleroderma	0.00766	0.0291	CbGeAlD
Vorinostat—HDAC1—smooth muscle tissue—systemic scleroderma	0.00755	0.0287	CbGeAlD
Vorinostat—HDAC1—skin of body—systemic scleroderma	0.00745	0.0283	CbGeAlD
Vorinostat—NCOR1—digestive system—systemic scleroderma	0.00743	0.0282	CbGeAlD
Vorinostat—HDAC8—lung—systemic scleroderma	0.00733	0.0278	CbGeAlD
Vorinostat—HDAC4—lung—systemic scleroderma	0.00712	0.027	CbGeAlD
Vorinostat—HDAC3—digestive system—systemic scleroderma	0.00651	0.0247	CbGeAlD
Vorinostat—HDAC11—lung—systemic scleroderma	0.00639	0.0243	CbGeAlD
Vorinostat—NCOR1—lung—systemic scleroderma	0.0062	0.0235	CbGeAlD
Vorinostat—HDAC3—tendon—systemic scleroderma	0.00619	0.0235	CbGeAlD
Vorinostat—HDAC1—digestive system—systemic scleroderma	0.00596	0.0226	CbGeAlD
Vorinostat—NR0B1—lung—systemic scleroderma	0.00582	0.0221	CbGeAlD
Vorinostat—HDAC1—tendon—systemic scleroderma	0.00567	0.0215	CbGeAlD
Vorinostat—HDAC9—tendon—systemic scleroderma	0.00558	0.0212	CbGeAlD
Vorinostat—HDAC3—lung—systemic scleroderma	0.00544	0.0206	CbGeAlD
Vorinostat—HDAC1—lung—systemic scleroderma	0.00498	0.0189	CbGeAlD
Vorinostat—HDAC9—lung—systemic scleroderma	0.0049	0.0186	CbGeAlD
Vorinostat—HDAC2—connective tissue—systemic scleroderma	0.00415	0.0158	CbGeAlD
Vorinostat—HDAC2—smooth muscle tissue—systemic scleroderma	0.0038	0.0144	CbGeAlD
Vorinostat—HDAC2—skin of body—systemic scleroderma	0.00375	0.0142	CbGeAlD
Vorinostat—HDAC2—digestive system—systemic scleroderma	0.003	0.0114	CbGeAlD
Vorinostat—HDAC2—tendon—systemic scleroderma	0.00285	0.0108	CbGeAlD
Vorinostat—HDAC2—lung—systemic scleroderma	0.0025	0.0095	CbGeAlD
Vorinostat—HDAC1—TGF-beta Signaling Pathway—COL1A2—systemic scleroderma	0.00186	0.00501	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—CENPC—systemic scleroderma	0.0018	0.00484	CbGpPWpGaD
Vorinostat—HDAC2—Regulation of nuclear SMAD2/3 signaling—COL1A2—systemic scleroderma	0.00177	0.00477	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—GDF15—systemic scleroderma	0.00176	0.00474	CbGpPWpGaD
Vorinostat—HDAC1—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.00172	0.00463	CbGpPWpGaD
Vorinostat—HDAC8—Mitotic M-M/G1 phases—CENPA—systemic scleroderma	0.00171	0.00459	CbGpPWpGaD
Vorinostat—HDAC2—Neural Crest Differentiation—RHOB—systemic scleroderma	0.00158	0.00424	CbGpPWpGaD
Vorinostat—HDAC4—Endochondral Ossification—MMP9—systemic scleroderma	0.00151	0.00407	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.0015	0.00404	CbGpPWpGaD
Vorinostat—HDAC3—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00147	0.00395	CbGpPWpGaD
Vorinostat—Angioedema—Mometasone—systemic scleroderma	0.00143	0.00404	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00142	0.004	CcSEcCtD
Vorinostat—Anorexia—Pentoxifylline—systemic scleroderma	0.00141	0.00398	CcSEcCtD
Vorinostat—HDAC4—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00141	0.00379	CbGpPWpGaD
Vorinostat—Weight decreased—Mycophenolic acid—systemic scleroderma	0.0014	0.00396	CcSEcCtD
Vorinostat—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.0014	0.00395	CcSEcCtD
Vorinostat—Abscess—Methotrexate—systemic scleroderma	0.0014	0.00394	CcSEcCtD
Vorinostat—Alopecia—Captopril—systemic scleroderma	0.0014	0.00394	CcSEcCtD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.00139	0.00375	CbGpPWpGaD
Vorinostat—Cough—Mometasone—systemic scleroderma	0.00137	0.00385	CcSEcCtD
Vorinostat—NR0B1—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.00136	0.00366	CbGpPWpGaD
Vorinostat—NCOR1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—systemic scleroderma	0.00135	0.00363	CbGpPWpGaD
Vorinostat—Dysgeusia—Captopril—systemic scleroderma	0.00135	0.0038	CcSEcCtD
Vorinostat—Chest pain—Mometasone—systemic scleroderma	0.00133	0.00376	CcSEcCtD
Vorinostat—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00374	CcSEcCtD
Vorinostat—Pancytopenia—Lisinopril—systemic scleroderma	0.00133	0.00374	CcSEcCtD
Vorinostat—HDAC2—Circadian rythm related genes—TOP1—systemic scleroderma	0.00132	0.00355	CbGpPWpGaD
Vorinostat—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00372	CcSEcCtD
Vorinostat—Neutropenia—Lisinopril—systemic scleroderma	0.00131	0.00369	CcSEcCtD
Vorinostat—Dry mouth—Mometasone—systemic scleroderma	0.0013	0.00368	CcSEcCtD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.0013	0.00351	CbGpPWpGaD
Vorinostat—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.0013	0.00366	CcSEcCtD
Vorinostat—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00364	CcSEcCtD
Vorinostat—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00129	0.00363	CcSEcCtD
Vorinostat—Oedema peripheral—Leflunomide—systemic scleroderma	0.00128	0.00362	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.00128	0.00344	CbGpPWpGaD
Vorinostat—Anaemia—Captopril—systemic scleroderma	0.00127	0.00359	CcSEcCtD
Vorinostat—Infection—Mometasone—systemic scleroderma	0.00127	0.00358	CcSEcCtD
Vorinostat—Constipation—Pentoxifylline—systemic scleroderma	0.00127	0.00357	CcSEcCtD
Vorinostat—HDAC6—Ectoderm Differentiation—CCL2—systemic scleroderma	0.00127	0.00341	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CENPC—systemic scleroderma	0.00127	0.0034	CbGpPWpGaD
Vorinostat—Weight decreased—Lisinopril—systemic scleroderma	0.00126	0.00357	CcSEcCtD
Vorinostat—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00126	0.00356	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—systemic scleroderma	0.00126	0.00355	CcSEcCtD
Vorinostat—Angioedema—Captopril—systemic scleroderma	0.00126	0.00354	CcSEcCtD
Vorinostat—HDAC4—Endochondral Ossification—TGFB1—systemic scleroderma	0.00125	0.00336	CbGpPWpGaD
Vorinostat—Protein urine present—Methotrexate—systemic scleroderma	0.00124	0.0035	CcSEcCtD
Vorinostat—HDAC1—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.00124	0.00334	CbGpPWpGaD
Vorinostat—Chills—Azathioprine—systemic scleroderma	0.00124	0.00349	CcSEcCtD
Vorinostat—Syncope—Captopril—systemic scleroderma	0.00123	0.00348	CcSEcCtD
Vorinostat—HDAC1—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.00123	0.00331	CbGpPWpGaD
Vorinostat—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00123	0.00347	CcSEcCtD
Vorinostat—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00122	0.00345	CcSEcCtD
Vorinostat—Myocardial infarction—Lisinopril—systemic scleroderma	0.00122	0.00345	CcSEcCtD
Vorinostat—Alopecia—Azathioprine—systemic scleroderma	0.00122	0.00344	CcSEcCtD
Vorinostat—Anorexia—Mometasone—systemic scleroderma	0.00122	0.00344	CcSEcCtD
Vorinostat—HDAC9—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	0.00122	0.00327	CbGpPWpGaD
Vorinostat—Loss of consciousness—Captopril—systemic scleroderma	0.00121	0.00341	CcSEcCtD
Vorinostat—Cough—Captopril—systemic scleroderma	0.0012	0.00339	CcSEcCtD
Vorinostat—Chest pain—Captopril—systemic scleroderma	0.00117	0.0033	CcSEcCtD
Vorinostat—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00117	0.0033	CcSEcCtD
Vorinostat—Chills—Leflunomide—systemic scleroderma	0.00117	0.0033	CcSEcCtD
Vorinostat—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00328	CcSEcCtD
Vorinostat—NCOR1—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.00116	0.00311	CbGpPWpGaD
Vorinostat—Alopecia—Leflunomide—systemic scleroderma	0.00115	0.00325	CcSEcCtD
Vorinostat—Sepsis—Prednisone—systemic scleroderma	0.00115	0.00324	CcSEcCtD
Vorinostat—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00323	CcSEcCtD
Vorinostat—Dry mouth—Captopril—systemic scleroderma	0.00115	0.00323	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—CENPA—systemic scleroderma	0.00114	0.00307	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CENPC—systemic scleroderma	0.00113	0.00304	CbGpPWpGaD
Vorinostat—Chills—Mycophenolic acid—systemic scleroderma	0.00111	0.00314	CcSEcCtD
Vorinostat—Decreased appetite—Mometasone—systemic scleroderma	0.00111	0.00313	CcSEcCtD
Vorinostat—Dysgeusia—Leflunomide—systemic scleroderma	0.00111	0.00313	CcSEcCtD
Vorinostat—Anaemia—Azathioprine—systemic scleroderma	0.00111	0.00313	CcSEcCtD
Vorinostat—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00313	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00111	0.00312	CcSEcCtD
Vorinostat—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00312	CcSEcCtD
Vorinostat—Shock—Captopril—systemic scleroderma	0.0011	0.00312	CcSEcCtD
Vorinostat—Oedema peripheral—Lisinopril—systemic scleroderma	0.0011	0.00311	CcSEcCtD
Vorinostat—Fatigue—Mometasone—systemic scleroderma	0.0011	0.00311	CcSEcCtD
Vorinostat—Thrombocytopenia—Captopril—systemic scleroderma	0.0011	0.0031	CcSEcCtD
Vorinostat—Alopecia—Mycophenolic acid—systemic scleroderma	0.0011	0.0031	CcSEcCtD
Vorinostat—HDAC6—Cellular responses to stress—IL1A—systemic scleroderma	0.0011	0.00295	CbGpPWpGaD
Vorinostat—Muscle spasms—Leflunomide—systemic scleroderma	0.00109	0.00307	CcSEcCtD
Vorinostat—HDAC2—Direct p53 effectors—IRF5—systemic scleroderma	0.00109	0.00293	CbGpPWpGaD
Vorinostat—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00304	CcSEcCtD
Vorinostat—Leukopenia—Azathioprine—systemic scleroderma	0.00107	0.00303	CcSEcCtD
Vorinostat—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00302	CcSEcCtD
Vorinostat—Anorexia—Captopril—systemic scleroderma	0.00107	0.00302	CcSEcCtD
Vorinostat—Asthenia—Pentoxifylline—systemic scleroderma	0.00106	0.003	CcSEcCtD
Vorinostat—Pruritus—Pentoxifylline—systemic scleroderma	0.00105	0.00296	CcSEcCtD
Vorinostat—Anaemia—Leflunomide—systemic scleroderma	0.00105	0.00296	CcSEcCtD
Vorinostat—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00104	0.00293	CcSEcCtD
Vorinostat—Angioedema—Leflunomide—systemic scleroderma	0.00104	0.00292	CcSEcCtD
Vorinostat—Leukopenia—Leflunomide—systemic scleroderma	0.00101	0.00286	CcSEcCtD
Vorinostat—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00101	0.00286	CcSEcCtD
Vorinostat—Body temperature increased—Mometasone—systemic scleroderma	0.00101	0.00285	CcSEcCtD
Vorinostat—Chills—Lisinopril—systemic scleroderma	0.001	0.00283	CcSEcCtD
Vorinostat—HDAC4—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.001	0.0027	CbGpPWpGaD
Vorinostat—Anaemia—Mycophenolic acid—systemic scleroderma	0.001	0.00282	CcSEcCtD
Vorinostat—Cough—Leflunomide—systemic scleroderma	0.000989	0.00279	CcSEcCtD
Vorinostat—Alopecia—Lisinopril—systemic scleroderma	0.000989	0.00279	CcSEcCtD
Vorinostat—Lethargy—Prednisone—systemic scleroderma	0.00098	0.00276	CcSEcCtD
Vorinostat—Dizziness—Pentoxifylline—systemic scleroderma	0.00098	0.00276	CcSEcCtD
Vorinostat—HDAC1—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.000979	0.00263	CbGpPWpGaD
Vorinostat—Decreased appetite—Captopril—systemic scleroderma	0.000976	0.00275	CcSEcCtD
Vorinostat—Infection—Azathioprine—systemic scleroderma	0.000973	0.00275	CcSEcCtD
Vorinostat—Syncope—Mycophenolic acid—systemic scleroderma	0.00097	0.00274	CcSEcCtD
Vorinostat—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000968	0.00273	CcSEcCtD
Vorinostat—Fatigue—Captopril—systemic scleroderma	0.000968	0.00273	CcSEcCtD
Vorinostat—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000966	0.00272	CcSEcCtD
Vorinostat—Chest pain—Leflunomide—systemic scleroderma	0.000965	0.00272	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000961	0.00271	CcSEcCtD
Vorinostat—Constipation—Captopril—systemic scleroderma	0.00096	0.00271	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—systemic scleroderma	0.00096	0.00271	CcSEcCtD
Vorinostat—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000959	0.00271	CcSEcCtD
Vorinostat—HDAC11—Disease—SMAD7—systemic scleroderma	0.000958	0.00258	CbGpPWpGaD
Vorinostat—Dysgeusia—Lisinopril—systemic scleroderma	0.000954	0.00269	CcSEcCtD
Vorinostat—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000951	0.00268	CcSEcCtD
Vorinostat—HDAC6—Cell Cycle—TGFB1—systemic scleroderma	0.00095	0.00256	CbGpPWpGaD
Vorinostat—Dry mouth—Leflunomide—systemic scleroderma	0.000944	0.00266	CcSEcCtD
Vorinostat—Cough—Mycophenolic acid—systemic scleroderma	0.000944	0.00266	CcSEcCtD
Vorinostat—HDAC1—Generic Transcription Pathway—SMAD7—systemic scleroderma	0.000943	0.00254	CbGpPWpGaD
Vorinostat—Vomiting—Pentoxifylline—systemic scleroderma	0.000942	0.00266	CcSEcCtD
Vorinostat—Muscle spasms—Lisinopril—systemic scleroderma	0.000937	0.00264	CcSEcCtD
Vorinostat—Headache—Pentoxifylline—systemic scleroderma	0.000928	0.00262	CcSEcCtD
Vorinostat—Chest pain—Mycophenolic acid—systemic scleroderma	0.000921	0.0026	CcSEcCtD
Vorinostat—Infection—Leflunomide—systemic scleroderma	0.000919	0.00259	CcSEcCtD
Vorinostat—HDAC3—Developmental Biology—RHOB—systemic scleroderma	0.000917	0.00247	CbGpPWpGaD
Vorinostat—Asthenia—Mometasone—systemic scleroderma	0.000917	0.00259	CcSEcCtD
Vorinostat—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000906	0.00255	CcSEcCtD
Vorinostat—Pruritus—Mometasone—systemic scleroderma	0.000904	0.00255	CcSEcCtD
Vorinostat—Dry mouth—Mycophenolic acid—systemic scleroderma	0.0009	0.00254	CcSEcCtD
Vorinostat—Anaemia—Lisinopril—systemic scleroderma	0.0009	0.00254	CcSEcCtD
Vorinostat—Angioedema—Lisinopril—systemic scleroderma	0.00089	0.00251	CcSEcCtD
Vorinostat—Body temperature increased—Captopril—systemic scleroderma	0.000887	0.0025	CcSEcCtD
Vorinostat—Anorexia—Leflunomide—systemic scleroderma	0.000882	0.00249	CcSEcCtD
Vorinostat—Nausea—Pentoxifylline—systemic scleroderma	0.00088	0.00248	CcSEcCtD
Vorinostat—Chills—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00248	CcSEcCtD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000877	0.00236	CbGpPWpGaD
Vorinostat—Infection—Mycophenolic acid—systemic scleroderma	0.000877	0.00247	CcSEcCtD
Vorinostat—HDAC11—Disease—TGFBI—systemic scleroderma	0.000876	0.00236	CbGpPWpGaD
Vorinostat—Diarrhoea—Mometasone—systemic scleroderma	0.000874	0.00247	CcSEcCtD
Vorinostat—Hypokalaemia—Prednisone—systemic scleroderma	0.000874	0.00247	CcSEcCtD
Vorinostat—Syncope—Lisinopril—systemic scleroderma	0.000874	0.00246	CcSEcCtD
Vorinostat—Leukopenia—Lisinopril—systemic scleroderma	0.000872	0.00246	CcSEcCtD
Vorinostat—Shock—Mycophenolic acid—systemic scleroderma	0.000868	0.00245	CcSEcCtD
Vorinostat—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000867	0.00233	CbGpPWpGaD
Vorinostat—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000866	0.00244	CcSEcCtD
Vorinostat—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000864	0.00244	CcSEcCtD
Vorinostat—HDAC4—Cell Cycle—TGFB1—systemic scleroderma	0.000859	0.00231	CbGpPWpGaD
Vorinostat—Loss of consciousness—Lisinopril—systemic scleroderma	0.000856	0.00241	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000851	0.0024	CcSEcCtD
Vorinostat—Cough—Lisinopril—systemic scleroderma	0.00085	0.0024	CcSEcCtD
Vorinostat—HDAC1—TGF-beta Signaling Pathway—MMP1—systemic scleroderma	0.000847	0.00228	CbGpPWpGaD
Vorinostat—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000846	0.00239	CcSEcCtD
Vorinostat—NCOR1—Developmental Biology—RHOB—systemic scleroderma	0.000843	0.00227	CbGpPWpGaD
Vorinostat—Anorexia—Mycophenolic acid—systemic scleroderma	0.000841	0.00237	CcSEcCtD
Vorinostat—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000836	0.00236	CcSEcCtD
Vorinostat—HDAC3—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000834	0.00225	CbGpPWpGaD
Vorinostat—Chest pain—Lisinopril—systemic scleroderma	0.000829	0.00234	CcSEcCtD
Vorinostat—NCOR1—Loss of Function of SMAD2/3 in Cancer—TGFB1—systemic scleroderma	0.000828	0.00223	CbGpPWpGaD
Vorinostat—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000821	0.00231	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—systemic scleroderma	0.000819	0.00231	CcSEcCtD
Vorinostat—Vomiting—Mometasone—systemic scleroderma	0.000813	0.00229	CcSEcCtD
Vorinostat—Dry mouth—Lisinopril—systemic scleroderma	0.000811	0.00229	CcSEcCtD
Vorinostat—Asthenia—Captopril—systemic scleroderma	0.000805	0.00227	CcSEcCtD
Vorinostat—Decreased appetite—Leflunomide—systemic scleroderma	0.000804	0.00227	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CENPA—systemic scleroderma	0.000804	0.00216	CbGpPWpGaD
Vorinostat—HDAC6—Disease—SMAD7—systemic scleroderma	0.000803	0.00216	CbGpPWpGaD
Vorinostat—Headache—Mometasone—systemic scleroderma	0.000801	0.00226	CcSEcCtD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000799	0.00215	CbGpPWpGaD
Vorinostat—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000799	0.00225	CcSEcCtD
Vorinostat—Fatigue—Leflunomide—systemic scleroderma	0.000798	0.00225	CcSEcCtD
Vorinostat—Pruritus—Captopril—systemic scleroderma	0.000794	0.00224	CcSEcCtD
Vorinostat—HDAC8—Cell Cycle—TGFB1—systemic scleroderma	0.000793	0.00213	CbGpPWpGaD
Vorinostat—Constipation—Leflunomide—systemic scleroderma	0.000791	0.00223	CcSEcCtD
Vorinostat—Infection—Lisinopril—systemic scleroderma	0.00079	0.00223	CcSEcCtD
Vorinostat—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000789	0.00222	CcSEcCtD
Vorinostat—Shock—Lisinopril—systemic scleroderma	0.000782	0.00221	CcSEcCtD
Vorinostat—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00078	0.0022	CcSEcCtD
Vorinostat—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000778	0.0022	CcSEcCtD
Vorinostat—Neutropenia—Prednisone—systemic scleroderma	0.000776	0.00219	CcSEcCtD
Vorinostat—Body temperature increased—Azathioprine—systemic scleroderma	0.000774	0.00218	CcSEcCtD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000772	0.00208	CbGpPWpGaD
Vorinostat—Diarrhoea—Captopril—systemic scleroderma	0.000768	0.00217	CcSEcCtD
Vorinostat—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000767	0.00216	CcSEcCtD
Vorinostat—NCOR1—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	0.000767	0.00206	CbGpPWpGaD
Vorinostat—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000765	0.00216	CcSEcCtD
Vorinostat—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000764	0.00215	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000762	0.00215	CcSEcCtD
Vorinostat—Fatigue—Mycophenolic acid—systemic scleroderma	0.000761	0.00215	CcSEcCtD
Vorinostat—HDAC1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	0.000761	0.00205	CbGpPWpGaD
Vorinostat—Nausea—Mometasone—systemic scleroderma	0.000759	0.00214	CcSEcCtD
Vorinostat—Anorexia—Lisinopril—systemic scleroderma	0.000758	0.00214	CcSEcCtD
Vorinostat—Constipation—Mycophenolic acid—systemic scleroderma	0.000755	0.00213	CcSEcCtD
Vorinostat—NR0B1—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000753	0.00202	CbGpPWpGaD
Vorinostat—Weight decreased—Prednisone—systemic scleroderma	0.000751	0.00212	CcSEcCtD
Vorinostat—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00212	CcSEcCtD
Vorinostat—Hyperglycaemia—Prednisone—systemic scleroderma	0.000749	0.00211	CcSEcCtD
Vorinostat—Cough—Mycophenolate mofetil—systemic scleroderma	0.000745	0.0021	CcSEcCtD
Vorinostat—Dizziness—Captopril—systemic scleroderma	0.000742	0.00209	CcSEcCtD
Vorinostat—HDAC1—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	0.000736	0.00198	CbGpPWpGaD
Vorinostat—HDAC6—Disease—TGFBI—systemic scleroderma	0.000734	0.00198	CbGpPWpGaD
Vorinostat—Body temperature increased—Leflunomide—systemic scleroderma	0.000731	0.00206	CcSEcCtD
Vorinostat—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00073	0.00206	CcSEcCtD
Vorinostat—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000727	0.00205	CcSEcCtD
Vorinostat—HDAC4—Disease—SMAD7—systemic scleroderma	0.000726	0.00195	CbGpPWpGaD
Vorinostat—Myocardial infarction—Prednisone—systemic scleroderma	0.000726	0.00205	CcSEcCtD
Vorinostat—HDAC1—Hemostasis—SELP—systemic scleroderma	0.000722	0.00194	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CENPA—systemic scleroderma	0.000719	0.00193	CbGpPWpGaD
Vorinostat—Vomiting—Captopril—systemic scleroderma	0.000714	0.00201	CcSEcCtD
Vorinostat—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000711	0.002	CcSEcCtD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.00071	0.00191	CbGpPWpGaD
Vorinostat—Headache—Captopril—systemic scleroderma	0.000703	0.00198	CcSEcCtD
Vorinostat—HDAC11—Disease—HSPG2—systemic scleroderma	0.000699	0.00188	CbGpPWpGaD
Vorinostat—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000698	0.00197	CcSEcCtD
Vorinostat—Infection—Mycophenolate mofetil—systemic scleroderma	0.000692	0.00195	CcSEcCtD
Vorinostat—Decreased appetite—Lisinopril—systemic scleroderma	0.000691	0.00195	CcSEcCtD
Vorinostat—HDAC1—Regulation of Telomerase—TGFB1—systemic scleroderma	0.00069	0.00186	CbGpPWpGaD
Vorinostat—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000686	0.00194	CcSEcCtD
Vorinostat—Fatigue—Lisinopril—systemic scleroderma	0.000685	0.00193	CcSEcCtD
Vorinostat—Shock—Mycophenolate mofetil—systemic scleroderma	0.000685	0.00193	CcSEcCtD
Vorinostat—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00192	CcSEcCtD
Vorinostat—Constipation—Lisinopril—systemic scleroderma	0.00068	0.00192	CcSEcCtD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.00068	0.00183	CbGpPWpGaD
Vorinostat—HDAC11—Disease—CSK—systemic scleroderma	0.000675	0.00182	CbGpPWpGaD
Vorinostat—HDAC1—Loss of Function of SMAD2/3 in Cancer—TGFB1—systemic scleroderma	0.000675	0.00182	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—RHOB—systemic scleroderma	0.000674	0.00181	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—SMAD7—systemic scleroderma	0.000671	0.00181	CbGpPWpGaD
Vorinostat—Diarrhoea—Azathioprine—systemic scleroderma	0.00067	0.00189	CcSEcCtD
Vorinostat—HDAC8—Disease—SMAD7—systemic scleroderma	0.00067	0.0018	CbGpPWpGaD
Vorinostat—Nausea—Captopril—systemic scleroderma	0.000667	0.00188	CcSEcCtD
Vorinostat—HDAC3—Cell Cycle—TGFB1—systemic scleroderma	0.000666	0.00179	CbGpPWpGaD
Vorinostat—HDAC4—Disease—TGFBI—systemic scleroderma	0.000664	0.00179	CbGpPWpGaD
Vorinostat—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00187	CcSEcCtD
Vorinostat—Asthenia—Leflunomide—systemic scleroderma	0.000664	0.00187	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—systemic scleroderma	0.000659	0.00186	CcSEcCtD
Vorinostat—NR0B1—Gene Expression—SMAD7—systemic scleroderma	0.000655	0.00176	CbGpPWpGaD
Vorinostat—Pruritus—Leflunomide—systemic scleroderma	0.000655	0.00185	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—systemic scleroderma	0.000649	0.00183	CcSEcCtD
Vorinostat—Dizziness—Azathioprine—systemic scleroderma	0.000648	0.00183	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000645	0.00182	CcSEcCtD
Vorinostat—NCOR1—Generic Transcription Pathway—CTGF—systemic scleroderma	0.00064	0.00172	CbGpPWpGaD
Vorinostat—HDAC11—Disease—CD247—systemic scleroderma	0.000635	0.00171	CbGpPWpGaD
Vorinostat—Asthenia—Mycophenolic acid—systemic scleroderma	0.000633	0.00179	CcSEcCtD
Vorinostat—Diarrhoea—Leflunomide—systemic scleroderma	0.000633	0.00179	CcSEcCtD
Vorinostat—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.000631	0.0017	CbGpPWpGaD
Vorinostat—Body temperature increased—Lisinopril—systemic scleroderma	0.000628	0.00177	CcSEcCtD
Vorinostat—HDAC9—Disease—SMAD7—systemic scleroderma	0.000627	0.00169	CbGpPWpGaD
Vorinostat—Pruritus—Mycophenolic acid—systemic scleroderma	0.000624	0.00176	CcSEcCtD
Vorinostat—Vomiting—Azathioprine—systemic scleroderma	0.000623	0.00176	CcSEcCtD
Vorinostat—HDAC1—Hemostasis—CSK—systemic scleroderma	0.000614	0.00165	CbGpPWpGaD
Vorinostat—Headache—Azathioprine—systemic scleroderma	0.000614	0.00173	CcSEcCtD
Vorinostat—HDAC8—Disease—TGFBI—systemic scleroderma	0.000613	0.00165	CbGpPWpGaD
Vorinostat—Dizziness—Leflunomide—systemic scleroderma	0.000612	0.00173	CcSEcCtD
Vorinostat—NR0B1—Gene Expression—TNFSF13—systemic scleroderma	0.000609	0.00164	CbGpPWpGaD
Vorinostat—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000606	0.00171	CcSEcCtD
Vorinostat—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000604	0.0017	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000601	0.0017	CcSEcCtD
Vorinostat—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00168	CcSEcCtD
Vorinostat—Vomiting—Leflunomide—systemic scleroderma	0.000588	0.00166	CcSEcCtD
Vorinostat—Alopecia—Prednisone—systemic scleroderma	0.000587	0.00166	CcSEcCtD
Vorinostat—HDAC6—Disease—HSPG2—systemic scleroderma	0.000586	0.00158	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000585	0.00157	CbGpPWpGaD
Vorinostat—Dizziness—Mycophenolic acid—systemic scleroderma	0.000584	0.00165	CcSEcCtD
Vorinostat—Nausea—Azathioprine—systemic scleroderma	0.000582	0.00164	CcSEcCtD
Vorinostat—Headache—Leflunomide—systemic scleroderma	0.00058	0.00163	CcSEcCtD
Vorinostat—HDAC1—Hemostasis—ITGAM—systemic scleroderma	0.000577	0.00155	CbGpPWpGaD
Vorinostat—HDAC9—Disease—TGFBI—systemic scleroderma	0.000573	0.00154	CbGpPWpGaD
Vorinostat—Asthenia—Lisinopril—systemic scleroderma	0.00057	0.00161	CcSEcCtD
Vorinostat—HDAC6—Disease—CSK—systemic scleroderma	0.000566	0.00152	CbGpPWpGaD
Vorinostat—HDAC3—Disease—SMAD7—systemic scleroderma	0.000563	0.00151	CbGpPWpGaD
Vorinostat—Pruritus—Lisinopril—systemic scleroderma	0.000562	0.00159	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—SMAD7—systemic scleroderma	0.000562	0.00151	CbGpPWpGaD
Vorinostat—Vomiting—Mycophenolic acid—systemic scleroderma	0.000561	0.00158	CcSEcCtD
Vorinostat—NCOR1—Gene Expression—SMAD7—systemic scleroderma	0.000557	0.0015	CbGpPWpGaD
Vorinostat—Headache—Mycophenolic acid—systemic scleroderma	0.000553	0.00156	CcSEcCtD
Vorinostat—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00155	CcSEcCtD
Vorinostat—Nausea—Leflunomide—systemic scleroderma	0.00055	0.00155	CcSEcCtD
Vorinostat—Diarrhoea—Lisinopril—systemic scleroderma	0.000544	0.00153	CcSEcCtD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	0.000538	0.00145	CbGpPWpGaD
Vorinostat—Anaemia—Prednisone—systemic scleroderma	0.000535	0.00151	CcSEcCtD
Vorinostat—HDAC6—Disease—CD247—systemic scleroderma	0.000532	0.00143	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HSPG2—systemic scleroderma	0.00053	0.00143	CbGpPWpGaD
Vorinostat—Angioedema—Prednisone—systemic scleroderma	0.000529	0.00149	CcSEcCtD
Vorinostat—Dizziness—Lisinopril—systemic scleroderma	0.000526	0.00148	CcSEcCtD
Vorinostat—Nausea—Mycophenolic acid—systemic scleroderma	0.000524	0.00148	CcSEcCtD
Vorinostat—HDAC1—Generic Transcription Pathway—CTGF—systemic scleroderma	0.000522	0.0014	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—RHOB—systemic scleroderma	0.000519	0.0014	CbGpPWpGaD
Vorinostat—Syncope—Prednisone—systemic scleroderma	0.000519	0.00146	CcSEcCtD
Vorinostat—NCOR1—Gene Expression—TNFSF13—systemic scleroderma	0.000518	0.00139	CbGpPWpGaD
Vorinostat—NCOR1—Disease—SMAD7—systemic scleroderma	0.000517	0.00139	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TGFBI—systemic scleroderma	0.000515	0.00139	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CSK—systemic scleroderma	0.000512	0.00138	CbGpPWpGaD
Vorinostat—Loss of consciousness—Prednisone—systemic scleroderma	0.000508	0.00143	CcSEcCtD
Vorinostat—HDAC4—Signaling Pathways—SMAD7—systemic scleroderma	0.000508	0.00137	CbGpPWpGaD
Vorinostat—Vomiting—Lisinopril—systemic scleroderma	0.000505	0.00143	CcSEcCtD
Vorinostat—NCOR1—Adipogenesis—TGFB1—systemic scleroderma	0.000504	0.00136	CbGpPWpGaD
Vorinostat—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0005	0.00141	CcSEcCtD
Vorinostat—HDAC1—Cell Cycle—TGFB1—systemic scleroderma	0.000499	0.00134	CbGpPWpGaD
Vorinostat—Chills—Methotrexate—systemic scleroderma	0.000498	0.00141	CcSEcCtD
Vorinostat—Headache—Lisinopril—systemic scleroderma	0.000498	0.0014	CcSEcCtD
Vorinostat—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00139	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—systemic scleroderma	0.000491	0.00138	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—HSPG2—systemic scleroderma	0.000489	0.00132	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HSPG2—systemic scleroderma	0.000489	0.00132	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CD247—systemic scleroderma	0.000481	0.00129	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	0.00048	0.00129	CbGpPWpGaD
Vorinostat—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00134	CcSEcCtD
Vorinostat—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic scleroderma	0.000474	0.00128	CbGpPWpGaD
Vorinostat—Dysgeusia—Methotrexate—systemic scleroderma	0.000473	0.00134	CcSEcCtD
Vorinostat—NCOR1—Disease—TGFBI—systemic scleroderma	0.000473	0.00127	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CSK—systemic scleroderma	0.000473	0.00127	CbGpPWpGaD
Vorinostat—Nausea—Lisinopril—systemic scleroderma	0.000472	0.00133	CcSEcCtD
Vorinostat—HDAC8—Disease—CSK—systemic scleroderma	0.000472	0.00127	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SMAD7—systemic scleroderma	0.000469	0.00126	CbGpPWpGaD
Vorinostat—Infection—Prednisone—systemic scleroderma	0.000469	0.00132	CcSEcCtD
Vorinostat—HDAC2—Hemostasis—SELP—systemic scleroderma	0.000465	0.00125	CbGpPWpGaD
Vorinostat—Shock—Prednisone—systemic scleroderma	0.000465	0.00131	CcSEcCtD
Vorinostat—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000461	0.0013	CcSEcCtD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	0.000457	0.00123	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HSPG2—systemic scleroderma	0.000457	0.00123	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—SMAD7—systemic scleroderma	0.000454	0.00122	CbGpPWpGaD
Vorinostat—Anorexia—Prednisone—systemic scleroderma	0.00045	0.00127	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—systemic scleroderma	0.000447	0.00126	CcSEcCtD
Vorinostat—HDAC2—Regulation of Telomerase—TGFB1—systemic scleroderma	0.000445	0.0012	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CD247—systemic scleroderma	0.000444	0.00119	CbGpPWpGaD
Vorinostat—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000443	0.00125	CcSEcCtD
Vorinostat—HDAC9—Disease—CSK—systemic scleroderma	0.000442	0.00119	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SMAD7—systemic scleroderma	0.000439	0.00118	CbGpPWpGaD
Vorinostat—Headache—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00123	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—RHOB—systemic scleroderma	0.000435	0.00117	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—RHOB—systemic scleroderma	0.000434	0.00117	CbGpPWpGaD
Vorinostat—Leukopenia—Methotrexate—systemic scleroderma	0.000433	0.00122	CcSEcCtD
Vorinostat—HDAC1—Gene Expression—TNFSF13—systemic scleroderma	0.000422	0.00114	CbGpPWpGaD
Vorinostat—Cough—Methotrexate—systemic scleroderma	0.000422	0.00119	CcSEcCtD
Vorinostat—HDAC1—Disease—SMAD7—systemic scleroderma	0.000422	0.00113	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CD247—systemic scleroderma	0.000415	0.00112	CbGpPWpGaD
Vorinostat—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00117	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—systemic scleroderma	0.000412	0.00116	CcSEcCtD
Vorinostat—HDAC3—Disease—HSPG2—systemic scleroderma	0.000411	0.00111	CbGpPWpGaD
Vorinostat—Decreased appetite—Prednisone—systemic scleroderma	0.00041	0.00116	CcSEcCtD
Vorinostat—HDAC6—Signaling Pathways—HSPG2—systemic scleroderma	0.00041	0.0011	CbGpPWpGaD
Vorinostat—Fatigue—Prednisone—systemic scleroderma	0.000407	0.00115	CcSEcCtD
Vorinostat—HDAC1—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	0.000406	0.00109	CbGpPWpGaD
Vorinostat—Constipation—Prednisone—systemic scleroderma	0.000404	0.00114	CcSEcCtD
Vorinostat—HDAC2—Direct p53 effectors—MMP2—systemic scleroderma	0.000403	0.00108	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CSK—systemic scleroderma	0.000397	0.00107	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CSK—systemic scleroderma	0.000396	0.00107	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—CSK—systemic scleroderma	0.000396	0.00106	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SMAD7—systemic scleroderma	0.000394	0.00106	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—RHOB—systemic scleroderma	0.000393	0.00106	CbGpPWpGaD
Vorinostat—Infection—Methotrexate—systemic scleroderma	0.000392	0.00111	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000386	0.00109	CcSEcCtD
Vorinostat—HDAC1—Disease—TGFBI—systemic scleroderma	0.000386	0.00104	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HSPG2—systemic scleroderma	0.000377	0.00102	CbGpPWpGaD
Vorinostat—Anorexia—Methotrexate—systemic scleroderma	0.000376	0.00106	CcSEcCtD
Vorinostat—Body temperature increased—Prednisone—systemic scleroderma	0.000373	0.00105	CcSEcCtD
Vorinostat—HDAC3—Disease—CD247—systemic scleroderma	0.000373	0.001	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—ITGAM—systemic scleroderma	0.000372	0.001	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HSPG2—systemic scleroderma	0.000371	0.000998	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CSK—systemic scleroderma	0.000365	0.000981	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RHOB—systemic scleroderma	0.000363	0.000977	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—CTGF—systemic scleroderma	0.000362	0.000975	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SMAD7—systemic scleroderma	0.000362	0.000975	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CSK—systemic scleroderma	0.000358	0.000964	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—HSPG2—systemic scleroderma	0.000344	0.000925	CbGpPWpGaD
Vorinostat—Decreased appetite—Methotrexate—systemic scleroderma	0.000343	0.000967	CcSEcCtD
Vorinostat—NCOR1—Disease—CD247—systemic scleroderma	0.000343	0.000922	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HSPG2—systemic scleroderma	0.000342	0.000921	CbGpPWpGaD
Vorinostat—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000341	0.000961	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—systemic scleroderma	0.00034	0.00096	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—RHOB—systemic scleroderma	0.00034	0.000914	CbGpPWpGaD
Vorinostat—Asthenia—Prednisone—systemic scleroderma	0.000339	0.000955	CcSEcCtD
Vorinostat—Pruritus—Prednisone—systemic scleroderma	0.000334	0.000942	CcSEcCtD
Vorinostat—HDAC8—Signaling Pathways—CSK—systemic scleroderma	0.000331	0.00089	CbGpPWpGaD
Vorinostat—Diarrhoea—Prednisone—systemic scleroderma	0.000323	0.000911	CcSEcCtD
Vorinostat—HDAC2—Cell Cycle—TGFB1—systemic scleroderma	0.000322	0.000866	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HSPG2—systemic scleroderma	0.00032	0.000861	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—HSPG2—systemic scleroderma	0.000316	0.00085	CbGpPWpGaD
Vorinostat—Dizziness—Prednisone—systemic scleroderma	0.000312	0.000881	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—systemic scleroderma	0.000312	0.00088	CcSEcCtD
Vorinostat—HDAC9—Signaling Pathways—CSK—systemic scleroderma	0.000309	0.000832	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—CTGF—systemic scleroderma	0.000308	0.000829	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HSPG2—systemic scleroderma	0.000308	0.000828	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RHOB—systemic scleroderma	0.000305	0.000821	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—MMP2—systemic scleroderma	0.000305	0.000819	CbGpPWpGaD
Vorinostat—Vomiting—Prednisone—systemic scleroderma	0.0003	0.000847	CcSEcCtD
Vorinostat—HDAC1—Disease—CSK—systemic scleroderma	0.000297	0.000799	CbGpPWpGaD
Vorinostat—Headache—Prednisone—systemic scleroderma	0.000296	0.000834	CcSEcCtD
Vorinostat—HDAC1—Signaling Pathways—SMAD7—systemic scleroderma	0.000295	0.000795	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SMAD7—systemic scleroderma	0.000293	0.000788	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—MMP1—systemic scleroderma	0.000289	0.000778	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HSPG2—systemic scleroderma	0.000288	0.000774	CbGpPWpGaD
Vorinostat—Asthenia—Methotrexate—systemic scleroderma	0.000283	0.000799	CcSEcCtD
Vorinostat—Nausea—Prednisone—systemic scleroderma	0.00028	0.000791	CcSEcCtD
Vorinostat—NCOR1—Signaling Pathways—RHOB—systemic scleroderma	0.00028	0.000754	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—MMP2—systemic scleroderma	0.00028	0.000753	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CD247—systemic scleroderma	0.000279	0.000752	CbGpPWpGaD
Vorinostat—Pruritus—Methotrexate—systemic scleroderma	0.000279	0.000787	CcSEcCtD
Vorinostat—HDAC3—Signaling Pathways—CSK—systemic scleroderma	0.000278	0.000747	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—TNFSF13—systemic scleroderma	0.000272	0.000732	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SMAD7—systemic scleroderma	0.000272	0.000731	CbGpPWpGaD
Vorinostat—Diarrhoea—Methotrexate—systemic scleroderma	0.00027	0.000761	CcSEcCtD
Vorinostat—HDAC11—Signaling Pathways—EDN1—systemic scleroderma	0.000265	0.000713	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HSPG2—systemic scleroderma	0.000264	0.000711	CbGpPWpGaD
Vorinostat—Dizziness—Methotrexate—systemic scleroderma	0.000261	0.000736	CcSEcCtD
Vorinostat—HDAC3—Metabolism—CTGF—systemic scleroderma	0.000261	0.000701	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CSK—systemic scleroderma	0.000255	0.000687	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—CTGF—systemic scleroderma	0.000251	0.000676	CbGpPWpGaD
Vorinostat—Vomiting—Methotrexate—systemic scleroderma	0.000251	0.000708	CcSEcCtD
Vorinostat—HDAC2—Disease—TGFBI—systemic scleroderma	0.000249	0.000669	CbGpPWpGaD
Vorinostat—Headache—Methotrexate—systemic scleroderma	0.000247	0.000697	CcSEcCtD
Vorinostat—NCOR1—Metabolism—CTGF—systemic scleroderma	0.00024	0.000645	CbGpPWpGaD
Vorinostat—Nausea—Methotrexate—systemic scleroderma	0.000234	0.000661	CcSEcCtD
Vorinostat—HDAC11—Disease—NOS3—systemic scleroderma	0.000231	0.00062	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—MMP9—systemic scleroderma	0.000229	0.000616	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RHOB—systemic scleroderma	0.000228	0.000615	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EDN1—systemic scleroderma	0.000222	0.000597	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HSPG2—systemic scleroderma	0.000215	0.00058	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—MMP9—systemic scleroderma	0.00021	0.000566	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—NOS3—systemic scleroderma	0.00021	0.000564	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CSK—systemic scleroderma	0.000208	0.00056	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EDN1—systemic scleroderma	0.000201	0.00054	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HSPG2—systemic scleroderma	0.000198	0.000533	CbGpPWpGaD
Vorinostat—HDAC6—Disease—NOS3—systemic scleroderma	0.000193	0.00052	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CSK—systemic scleroderma	0.000191	0.000515	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMAD7—systemic scleroderma	0.00019	0.000512	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—TGFB1—systemic scleroderma	0.000189	0.000508	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—MMP1—systemic scleroderma	0.000186	0.000501	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EDN1—systemic scleroderma	0.000185	0.000499	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CCL2—systemic scleroderma	0.000181	0.000487	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD247—systemic scleroderma	0.00018	0.000484	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NOS3—systemic scleroderma	0.000175	0.00047	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EDN1—systemic scleroderma	0.000173	0.000466	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—TGFB1—systemic scleroderma	0.000173	0.000466	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—CTGF—systemic scleroderma	0.000162	0.000435	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NOS3—systemic scleroderma	0.000161	0.000434	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NOS3—systemic scleroderma	0.000161	0.000434	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EDN1—systemic scleroderma	0.000156	0.000419	CbGpPWpGaD
Vorinostat—HDAC11—Disease—TGFB1—systemic scleroderma	0.000152	0.00041	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CCL2—systemic scleroderma	0.000152	0.000408	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NOS3—systemic scleroderma	0.000151	0.000406	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RHOB—systemic scleroderma	0.000147	0.000396	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EDN1—systemic scleroderma	0.000143	0.000385	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HSPG2—systemic scleroderma	0.000139	0.000374	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TGFB1—systemic scleroderma	0.000139	0.000373	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CCL2—systemic scleroderma	0.000137	0.000369	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NOS3—systemic scleroderma	0.000135	0.000365	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NOS3—systemic scleroderma	0.000135	0.000364	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NOS3—systemic scleroderma	0.000135	0.000363	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CSK—systemic scleroderma	0.000134	0.000361	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MMP9—systemic scleroderma	0.00013	0.000349	CbGpPWpGaD
Vorinostat—HDAC6—Disease—TGFB1—systemic scleroderma	0.000128	0.000344	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCL2—systemic scleroderma	0.000127	0.000341	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NOS3—systemic scleroderma	0.000125	0.000335	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NOS3—systemic scleroderma	0.000122	0.000329	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCL2—systemic scleroderma	0.000119	0.000319	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EDN1—systemic scleroderma	0.000117	0.000314	CbGpPWpGaD
Vorinostat—HDAC4—Disease—TGFB1—systemic scleroderma	0.000116	0.000311	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—NOS3—systemic scleroderma	0.000113	0.000305	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NOS3—systemic scleroderma	0.000113	0.000304	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MMP9—systemic scleroderma	0.000109	0.000292	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TGFB1—systemic scleroderma	0.000107	0.000287	CbGpPWpGaD
Vorinostat—HDAC8—Disease—TGFB1—systemic scleroderma	0.000107	0.000287	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCL2—systemic scleroderma	0.000106	0.000286	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NOS3—systemic scleroderma	0.000106	0.000284	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—NOS3—systemic scleroderma	0.000104	0.000281	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS3—systemic scleroderma	0.000101	0.000273	CbGpPWpGaD
Vorinostat—HDAC9—Disease—TGFB1—systemic scleroderma	9.97e-05	0.000268	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MMP9—systemic scleroderma	9.82e-05	0.000264	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCL2—systemic scleroderma	9.78e-05	0.000263	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOS3—systemic scleroderma	9.49e-05	0.000255	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MMP9—systemic scleroderma	9.06e-05	0.000244	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TGFB1—systemic scleroderma	8.96e-05	0.000241	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TGFB1—systemic scleroderma	8.95e-05	0.000241	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TGFB1—systemic scleroderma	8.93e-05	0.00024	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOS3—systemic scleroderma	8.72e-05	0.000235	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MMP9—systemic scleroderma	8.47e-05	0.000228	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TGFB1—systemic scleroderma	8.23e-05	0.000222	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TGFB1—systemic scleroderma	8.09e-05	0.000218	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCL2—systemic scleroderma	7.97e-05	0.000215	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—systemic scleroderma	7.61e-05	0.000205	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EDN1—systemic scleroderma	7.52e-05	0.000202	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TGFB1—systemic scleroderma	7.47e-05	0.000201	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOS3—systemic scleroderma	7.11e-05	0.000191	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—systemic scleroderma	7e-05	0.000188	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TGFB1—systemic scleroderma	6.98e-05	0.000188	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TGFB1—systemic scleroderma	6.71e-05	0.000181	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS3—systemic scleroderma	6.54e-05	0.000176	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TGFB1—systemic scleroderma	6.27e-05	0.000169	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TGFB1—systemic scleroderma	5.77e-05	0.000155	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—systemic scleroderma	5.7e-05	0.000153	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCL2—systemic scleroderma	5.14e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TGFB1—systemic scleroderma	4.7e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOS3—systemic scleroderma	4.58e-05	0.000123	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TGFB1—systemic scleroderma	4.32e-05	0.000116	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—systemic scleroderma	3.67e-05	9.89e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFB1—systemic scleroderma	3.03e-05	8.15e-05	CbGpPWpGaD
